Literature DB >> 1386604

Localization and characterization of a 7.3-kDa region of caldesmon which reversibly inhibits actomyosin ATPase activity.

J M Chalovich1, J Bryan, C E Benson, L Velaz.   

Abstract

Cleavage of caldesmon with chymotrypsin yields a series of fragments which bind both calmodulin and actin and inhibit the binding of myosin subfragments to actin and the subsequent stimulation of ATPase activity. Several of these fragments have been purified by cation exchange chromatography and their amino-terminal sequences determined. The smallest fragment has a molecular mass of about 7.3 kDa and extends from Leu597 to Phe665. This polypeptide inhibits the actin-activated ATPase of myosin S-1; this inhibition is augmented by smooth muscle tropomyosin and relieved by Ca(2+)-calmodulin. The binding of the 7.3-kDa fragment to actin is competitive with the binding of S-1 to actin. Thus, this polypeptide has several of the important features characteristic of intact caldesmon. However, although an intact caldesmon molecule covers between six and nine actin monomers, the 7.3-kDa fragment binds to actin in a 1:1 complex. Comparison of this fragment with others suggests that a small region of caldesmon is responsible for at least part of the interaction with both calmodulin and actin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386604      PMCID: PMC1262679     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  The effects of phosphorylation of smooth-muscle caldesmon.

Authors:  P K Ngai; M P Walsh
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

2.  Effect of caldesmon on the ATPase activity and the binding of smooth and skeletal myosin subfragments to actin.

Authors:  M E Hemric; J M Chalovich
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  A 35-kilodalton fragment from gizzard smooth muscle caldesmon that induces F-actin bundles.

Authors:  D Mornet; M C Harricane; E Audemard
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

4.  Isolation and characterization of a calmodulin binding fragment of chicken gizzard caldesmon.

Authors:  M Yazawa; K Yagi; K Sobue
Journal:  J Biochem       Date:  1987-11       Impact factor: 3.387

5.  Identification of a 15 kilodalton actin binding region on gizzard caldesmon probed by chemical cross-linking.

Authors:  D Mornet; E Audemard; J Derancourt
Journal:  Biochem Biophys Res Commun       Date:  1988-07-29       Impact factor: 3.575

6.  Evidence for interaction between smooth muscle tropomyosin and caldesmon.

Authors:  P Graceffa
Journal:  FEBS Lett       Date:  1987-06-22       Impact factor: 4.124

7.  Photocrosslinking of calmodulin and/or actin to chicken gizzard caldesmon.

Authors:  C L Wang
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

8.  Mapping of caldesmon: relationship between the high and low molecular weight forms.

Authors:  E H Ball; T Kovala
Journal:  Biochemistry       Date:  1988-08-09       Impact factor: 3.162

9.  Caldesmon inhibits skeletal actomyosin subfragment-1 ATPase activity and the binding of myosin subfragment-1 to actin.

Authors:  J M Chalovich; P Cornelius; C E Benson
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

10.  Binding of caldesmon to smooth muscle myosin.

Authors:  M Ikebe; S Reardon
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

View more
  12 in total

Review 1.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

2.  Parallel inhibition of active force and relaxed fiber stiffness by caldesmon fragments at physiological ionic strength and temperature conditions: additional evidence that weak cross-bridge binding to actin is an essential intermediate for force generation.

Authors:  T Kraft; J M Chalovich; L C Yu; B Brenner
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

3.  The size and shape of caldesmon and its fragments in solution studied by dynamic light scattering and hydrodynamic model calculations.

Authors:  E A Czuryło; T Hellweg; W Eimer; R Dabrowska
Journal:  Biophys J       Date:  1997-02       Impact factor: 4.033

4.  Inhibition of cross-bridge binding to actin by caldesmon fragments in skinned skeletal muscle fibers.

Authors:  J F Heubach; R Hartwell; M Ledwon; T Kraft; B Brenner; J M Chalovich
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

5.  Characterization of the functional properties of smooth muscle caldesmon domain 4a: evidence for an independent inhibitory actin-tropomyosin binding domain.

Authors:  M El-Mezgueldi; O Copeland; I D Fraser; S B Marston; P A Huber
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

6.  Kinetics of binding of caldesmon to actin.

Authors:  J M Chalovich; Y D Chen; R Dudek; H Luo
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

7.  Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.

Authors:  L Velaz; Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

8.  Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.

Authors:  G Pfitzer; C Zeugner; M Troschka; J M Chalovich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

10.  Flexation of caldesmon: effect of conformation on the properties of caldesmon.

Authors:  R H Crosbie; J M Chalovich; E Reisler
Journal:  J Muscle Res Cell Motil       Date:  1995-10       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.